End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
6.2
CNY
|
+0.16%
|
|
+1.64%
|
-0.48%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
4,047
|
6,904
|
6,201
|
9,693
|
7,303
|
6,954
|
Enterprise Value (EV)
1 |
3,331
|
6,230
|
5,544
|
9,102
|
7,071
|
6,398
|
P/E ratio
|
36.1
x
|
48.4
x
|
60.8
x
|
71.8
x
|
28.4
x
|
80.3
x
|
Yield
|
-
|
-
|
-
|
-
|
1.24%
|
0.43%
|
Capitalization / Revenue
|
1.9
x
|
2.75
x
|
2.38
x
|
2.58
x
|
1.54
x
|
1.81
x
|
EV / Revenue
|
1.56
x
|
2.48
x
|
2.13
x
|
2.42
x
|
1.49
x
|
1.66
x
|
EV / EBITDA
|
17.1
x
|
26.4
x
|
41.4
x
|
44.9
x
|
21.2
x
|
28.6
x
|
EV / FCF
|
-24
x
|
229
x
|
-115
x
|
-69.4
x
|
-15.4
x
|
14.5
x
|
FCF Yield
|
-4.16%
|
0.44%
|
-0.87%
|
-1.44%
|
-6.51%
|
6.87%
|
Price to Book
|
1.85
x
|
3
x
|
2.65
x
|
3.92
x
|
2.69
x
|
2.65
x
|
Nbr of stocks (in thousands)
|
1,133,684
|
1,133,684
|
1,133,684
|
1,133,684
|
1,125,200
|
1,116,251
|
Reference price
2 |
3.570
|
6.090
|
5.470
|
8.550
|
6.490
|
6.230
|
Announcement Date
|
3/7/19
|
3/12/20
|
3/12/21
|
3/11/22
|
3/10/23
|
3/14/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,135
|
2,513
|
2,601
|
3,760
|
4,732
|
3,849
|
EBITDA
1 |
194.4
|
236
|
133.8
|
202.9
|
333.9
|
224.1
|
EBIT
1 |
119
|
143.9
|
48.76
|
95.95
|
235.1
|
123.4
|
Operating Margin
|
5.58%
|
5.73%
|
1.87%
|
2.55%
|
4.97%
|
3.21%
|
Earnings before Tax (EBT)
1 |
153.4
|
170.3
|
74.75
|
129.9
|
268.2
|
107.8
|
Net income
1 |
112.2
|
142.5
|
102.1
|
135.4
|
258.5
|
86.71
|
Net margin
|
5.25%
|
5.67%
|
3.93%
|
3.6%
|
5.46%
|
2.25%
|
EPS
2 |
0.0989
|
0.1257
|
0.0900
|
0.1190
|
0.2287
|
0.0776
|
Free Cash Flow
1 |
-138.6
|
27.25
|
-48.05
|
-131.2
|
-460.1
|
439.8
|
FCF margin
|
-6.49%
|
1.08%
|
-1.85%
|
-3.49%
|
-9.72%
|
11.43%
|
FCF Conversion (EBITDA)
|
-
|
11.54%
|
-
|
-
|
-
|
196.28%
|
FCF Conversion (Net income)
|
-
|
19.12%
|
-
|
-
|
-
|
507.21%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
0.0802
|
0.0270
|
Announcement Date
|
3/7/19
|
3/12/20
|
3/12/21
|
3/11/22
|
3/10/23
|
3/14/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
717
|
675
|
657
|
591
|
231
|
556
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-139
|
27.2
|
-48.1
|
-131
|
-460
|
440
|
ROE (net income / shareholders' equity)
|
5.61%
|
6.17%
|
3.08%
|
3.97%
|
9.2%
|
3.44%
|
ROA (Net income/ Total Assets)
|
2.72%
|
2.73%
|
0.82%
|
1.42%
|
3.12%
|
1.69%
|
Assets
1 |
4,131
|
5,226
|
12,440
|
9,512
|
8,298
|
5,139
|
Book Value Per Share
2 |
1.930
|
2.030
|
2.060
|
2.180
|
2.410
|
2.350
|
Cash Flow per Share
2 |
0.3100
|
0.4800
|
0.8000
|
0.2900
|
0.7500
|
0.7100
|
Capex
1 |
103
|
151
|
121
|
146
|
138
|
89.4
|
Capex / Sales
|
4.82%
|
6%
|
4.65%
|
3.9%
|
2.91%
|
2.32%
|
Announcement Date
|
3/7/19
|
3/12/20
|
3/12/21
|
3/11/22
|
3/10/23
|
3/14/24
|
|
1st Jan change
|
Capi.
|
---|
| -0.48% | 956M | | -1.20% | 66.01B | | +47.62% | 41.76B | | +15.99% | 38.66B | | +4.25% | 32.28B | | +8.78% | 19.57B | | +12.32% | 16.77B | | +17.69% | 15.08B | | +8.31% | 14.83B | | -14.59% | 13.95B |
Other Commodity Chemicals
|